Research Study

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II
Principal Investigator 
Ryan F. Paterson

Overview

Body Locations and Systems 
Prostate Diseases
ClinicalTrials.gov# 
NCT03123250
Status 
Recruiting
Study Start/End 
Oct 25, 2017 to Aug 31, 2020
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Lynn Cunada, RN
Phone 
604-875-5077
Purpose of Study 

Single-arm, interventional pivotal clinical trial collecting patient data from use of the AQUABEAM System, a personalized image-guided waterjet resection system that utilizes a high-velocity saline stream to resect and remove prostate tissue in males suffering from Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH).The primary endpoints for safety and effectiveness will be measured at 3 months post-treatment. All treated subjects will be followed out to 12 months to collect long-term clinical data.

Eligibility 

Inclusion Criteria:

Subject has diagnosis of lower urinary tract symptoms due to benign prostatic enlargement causing bladder outlet obstruction.

Exclusion Criteria:

Any severe illness that would prevent complete study participation or confound study results.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.